News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments. Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More
Inspirata
Caradigm Sale – The Final Step in GE’s Exit From PHM/Value-based Care?
- On 13th June 2018, cancer informatics and digital pathology workflow vendor, Inspirata, announced that it was purchasing GE Healthcare’s remaining population health management (PHM) interest, Caradigm- This follows the announcement in April 2018 that GE Healthcare was selling its ambulatory value-based care business to Veritas Capital- This latest announcement now means that GE Healthcare has exited the population health management market from both an enterprise and ambulatory perspective- It
Read More
Inspirata Acquires Caradigm to Expand its Cancer Information Data Trust
Inspirata, Inc., a Redmond, VA-based cancer informatics and digital pathology workflow solution, today announced it has acquired Caradigm from GE Healthcare. Inspirata plans to leverage Caradigm Intelligence Platform (CIP) and population health management platform to accelerate our Cancer Information Data Trust (CIDT) development. Inspirata’s Cancer Information Data Trust (CIDT) is a cancer big data platform that securely ingests, structures and manages clinical data, diagnostic images, anatomic
Read More
